Intravenous iron exposure and outcomes in patients on hemodialysis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. Ferric pyrophosphate citrate administered via dialysate reduces erythropoiesis-stimulating agent use and maintains hemoglobin in hemodialysis patients.Kidney international · 2015
   Trial
2. Serum ferritin and neutrophil-to-lymphocyte ratio predict all-cause mortality in patients receiving maintenance hemodialysis: a prospective study.Frontiers in molecular biosciences · 2024
   Article
3. Trends in the treatment of chronic kidney disease-associated anaemia in a cohort of haemodialysis patients: the Irish experience.Irish journal of medical science · 2019
   Article
4. Comparison of Methods Study between a Photonic Crystal Biosensor and Certified ELISA to Measure Biomarkers of Iron Deficiency in Chronic Kidney Disease Patients.Sensors (Basel, Switzerland) · 2017
   Article
5. Longitudinal trends in serum ferritin levels and associated factors in a national incident hemodialysis cohort.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2017
   Article
6. Serum Ferritin Variations and Mortality in Incident Hemodialysis Patients.American journal of nephrology · 2017
   Article
7. The Labile Side of Iron Supplementation in CKD.Journal of the American Society of Nephrology : JASN · 2015
   Review

Corrections and comments

• Comment on
  Intravenous iron exposure and mortality in patients on hemodialysis.2014

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as